{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:52:55Z","timestamp":1794646375274,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421089"],"award-info":[{"award-number":["242300421089"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232301420064"],"award-info":[{"award-number":["232301420064"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271463"],"award-info":[{"award-number":["32271463"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102685","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:15:27Z","timestamp":1773760527000},"page":"102685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blood-brain barrier-penetrative lipid nanoparticles enable systemic delivery of TRIM11 mRNA to disaggregate Tau in Alzheimer\u2019s disease models"],"prefix":"10.1016","volume":"7","author":[{"given":"Yan","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102685_bib1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s41593-024-01732-1","article-title":"Neutrophil-microglia interactions in AD","volume":"27","author":"Welberg","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102685_bib2","first-page":"643","article-title":"Lewy body pathology accelerates AD progression","volume":"20","author":"Wood","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2026.102685_bib3","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.cell.2023.09.001","article-title":"The AD odyssey 2023: Tales of single cell","volume":"186","author":"Luo","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102685_bib4","first-page":"326","article-title":"Cytomegalovirus link to concussion changes","volume":"19","author":"Lempri\u00e8re","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2026.102685_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41593-023-01346-z","article-title":"A motor association area in the depths of the central sulcus","volume":"26","author":"Jensen","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102685_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","article-title":"New approaches to symptomatic treatments for Alzheimer's disease","volume":"16","author":"Cummings","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.xcrm.2026.102685_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102685_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102685_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.xcrm.2026.102685_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102685_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.xcrm.2026.102685_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer's disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102685_bib13","article-title":"Integrative proteomics identifies a conserved A\u03b2 amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease","volume":"5","author":"Levites","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102685_bib14","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.cell.2024.08.024","article-title":"Co-opting templated aggregation to degrade pathogenic Tau assemblies and improve motor function","volume":"187","author":"Miller","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102685_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/17460441.2018.1445084","article-title":"Recent developments with Tau-based drug discovery","volume":"13","author":"Iqbal","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102685_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41467-023-36058-2","article-title":"The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system","volume":"14","author":"Saha","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102685_bib17","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","article-title":"Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived Tau fibrils in vitro","volume":"13","author":"Seidler","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102685_bib18","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1038\/onc.2012.531","article-title":"TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth","volume":"32","author":"Di","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.102685_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/s41593-023-01429-x","article-title":"TRIMming Tau away","volume":"26","author":"Perez-Nievas","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102685_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6696","article-title":"TRIM11 protects against Tauopathies and is down-regulated in Alzheimer's disease","volume":"381","author":"Zhang","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102685_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-023-01729-5","article-title":"Tripartite motif-containing protein 11 (TRIM11): a novel weapon against Alzheimer's disease","volume":"9","author":"Fu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102685_bib22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.xcrm.2026.102685_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102685_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113641","article-title":"Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases","volume":"381","author":"Moosavi","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.102685_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.xcrm.2026.102685_bib26","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-025-59489-5","article-title":"Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes","volume":"16","author":"Son","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102685_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2026.102685_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41577-021-00504-3","article-title":"mRNA vaccine shows promise in autoimmunity","volume":"21","author":"Flemming","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102685_bib29","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/bm701301s","article-title":"Zwitterionic Polymers Exhibiting High Resistance to Nonspecific Protein Adsorption from Human Serum and Plasma","volume":"9","author":"Ladd","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.xcrm.2026.102685_bib30","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1021\/acsnano.7b01110","article-title":"Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol","volume":"11","author":"Jackson","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2026.102685_bib31","article-title":"A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System","volume":"31","author":"Wu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.102685_bib32","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.7150\/thno.58947","article-title":"Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke","volume":"11","author":"Jin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2026.102685_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/cells10020453","article-title":"Functional Expression of Choline Transporters in Human Neural Stem Cells and Its Link to Cell Proliferation, Cell Viability, and Neurite Outgrowth","volume":"10","author":"Fujita","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.102685_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2026.102685_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114505","article-title":"The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3\u00d7Tg-AD) mouse model strain","volume":"368","author":"Tian","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.xcrm.2026.102685_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01525-2","article-title":"Targeted clearance of extracellular Tau using aptamer-armed monocytes alleviates neuroinflammation in mice with Alzheimer\u2019s disease","author":"Zhuo","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102685_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102685_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12873","article-title":"Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice","volume":"18","author":"Belfiore","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2026.102685_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer's Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102685_bib40","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2026.102685_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102685_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41587-025-02565-4","article-title":"Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargo","volume":"44","author":"Coughlin","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102685_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","article-title":"Current landscape of mRNA technologies and delivery systems for new modality therapeutics","volume":"31","author":"Lu","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.xcrm.2026.102685_bib44","article-title":"Carbonic Anhydrase Inhibitors rescue microvascular impairment and neuroinflammation in 3xTg AD mice","volume":"20","author":"Canepa","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xcrm.2026.102685_bib45","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102685_bib46","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:25:33Z","timestamp":1783095933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126001023"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102685","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier-penetrative lipid nanoparticles enable systemic delivery of TRIM11 mRNA to disaggregate Tau in Alzheimer\u2019s disease models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102685"}}